MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Oncogene

• Publication date

  2018-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2017.381PMID 29059152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The multifaceted roles of inflammasome proteins in cancer

  2017cited by this paper
• Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

  2016cited by this paper
• NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer

  2016cited by this paper
• The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3

  2016cited by this paper
• Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

  2016cited by this paper
• Mint3 potentiates TLR3/4- and RIG-I–induced IFN-β expression and antiviral immune responses

  2016cited by this paper
• IL-1β/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis.

  2016cited by this paper
• NLRC5/MHC class I transactivator is a target for immune evasion in cancer

  2016cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail

  2015cited by this paper
• The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

  2015cited by this paper
• miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.

  2015cited by this paper
• Modification of Helicobacter pylori Peptidoglycan Enhances NOD1 Activation and Promotes Cancer of the Stomach.

  2015cited by this paper
• A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

  2015cited by this paper
• MiR-22-silenced Cyclin A Expression in Colon and Liver Cancer Cells Is Regulated by Bile Acid Receptor*

  2015cited by this paper
• Inflammatory IL‐1β‐driven JNK activation in stage III melanoma

  2015cited by this paper
• Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.

  2015cited by this paper
• Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription

  2014cited by this paper
• Pattern-Recognition Receptors and Gastric Cancer

  2014cited by this paper
• Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer

  2014cited by this paper
• MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.

  2014cited by this paper
• Helicobacter pylori–Induced IL-1β Secretion in Innate Immune Cells Is Regulated by the NLRP3 Inflammasome and Requires the Cag Pathogenicity Island

  2014cited by this paper
• Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression

  2014cited by this paper
• The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses

  2014cited by this paper
• Nucleotide Oligomerization Domain 1 Enhances IFN-γ Signaling in Gastric Epithelial Cells during Helicobacter pylori Infection and Exacerbates Disease Severity

  2013cited by this paper
• NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.

  2013cited by this paper
• Role of the Helicobacter pylori‐Induced inflammatory response in the development of gastric cancer

  2013cited by this paper
• Biochemical regulation of the inflammasome

  2012cited by this paper
• Expression of melanoma differentiation associated gene 5 is increased in human gastric mucosa infected with Helicobacter pylori

  2012cited by this paper
• MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.

  2012cited by this paper
• NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223

  2012cited by this paper
• Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma

  2012cited by this paper
• Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.

  2012cited by this paper
• NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.

  2012cited by this paper
• This information is current as Production β Inflammasome and IL-1 miR-BART 15 Regulate the NLRP 3 Cutting Edge : miR-223 and EBV

  2012cited by this paper
• Inflammasomes in health and disease

  2012cited by this paper
• miR-22 represses cancer progression by inducing cellular senescence

  2011cited by this paper
• The inflammasome NLRs in immunity, inflammation, and associated diseases.

  2011cited by this paper
• The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.

  2010cited by this paper
• Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

  2010cited by this paper
• Signal integration by JNK and p38 MAPK pathways in cancer development

  2009cited by this paper
• Gastric cancer

  2009cited by this paper
• and Gastric Cancer

  2009cited by this paper
• Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells

  2008cited by this paper
• Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

  2008cited by this paper
• Inflammation, atrophy, and gastric cancer.

  2007cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Inflammation, a Key Event in Cancer Development

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• The Selective Cyclooxygenase-2 Inhibitor Nimesulide Prevents Helicobacter pylori-Associated Gastric Cancer Development in a Mouse Model

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Interleukin-1 polymorphisms associated with increased risk of gastric cancer

  2000cited by this paper

• Histone demethylase KDM4B epigenetically controls NLRP3 expression to enhance inflammatory responses.

  2026cites this paper
• De novo discovery of bicyclic cysteine-rich peptides targeting gasdermin D.

  2026cites this paper
• Caspase-1 in cancer and inflammatory diseases: a potential therapeutic target.

  2026cites this paper
• Nanomaterial-Driven Regulated Cell Death: Mechanistic Insights and Novel Strategies for Tumor Therapy

  2025cites this paper
• NLRP3 inflammasome inhibition by MCC950 reduces embryo implantation during early pregnancy in mice

  2025cites this paper
• Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies

  2025cites this paper
• The emerging role of miR-22 in inflammation.

  2025cites this paper
• Pyroptosis in gastric mucosal injury-related diseases (Review)

  2025cites this paper
• Microbiota-driven epigenetic modifications in gastrointestinal cancer: Implications for pathogenesis and therapeutic strategies

  2025cites this paper
• Gastrointestinal inflammation and cancer: viral and bacterial interplay

  2025cites this paper
• The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy.

  2025cites this paper
• NLRP3 inflammasome: From drug target to drug discovery.

  2025cites this paper
• Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential

  2025cites this paper
• The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes

  2025cites this paper
• Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis

  2025cites this paper
• Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches

  2025cites this paper
• Mechanism of Yinxu Weitong Capsule in the treatment of precancerous lesions of gastric cancer based on network pharmacology and experimental validation.

  2025cites this paper
• NLRP3 inflammasome in health and disease (Review)

  2025cites this paper
• Nrf2–Keap1 Pathway and NLRP3 Inflammasome in Parkinson’s Disease: Mechanistic Crosstalk and Therapeutic Implications

  2025cites this paper
• Panax notoginseng-Bletilla striata ameliorates reflux esophagitis by modulating NLRP3 inflammasomes and p38 MAPK pathway

  2025cites this paper
• Regulation of Neuronal Pyroptosis Through NLRP3 by Delivering miR-22 Using Lipid Nanoparticles in Mice with Cerebral Ischemia-Reperfusion Injury

  2024cites this paper
• MALAT1 promotes colonic epithelial cell apoptosis and pyroptosis by sponging miR-22-3p to enhance NLRP3 expression

  2024cites this paper
• Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune landscapes in patients with gastric adenocarcinoma

  2024cites this paper
• Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome

  2024cites this paper
• Pyroptosis and chemical classification of pyroptotic agents

  2024cites this paper
• The Association between the NLRP3 Inflammasome and Specific Long-Non Coding RNAs (lncRNAs) in Cancer; New Perspective and Summary of Recent Studies

  2024cites this paper
• Britannilactone 1-O-acetate induced ubiquitination of NLRP3 inflammasome through TRIM31 as a protective mechanism against reflux esophagitis-induced esophageal injury

  2024cites this paper
• A novel prognostic model based on pyroptosis signature in AML

  2024cites this paper
• Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis

  2024cites this paper
• MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application.

  2024cites this paper
• Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: from mechanisms to therapy.

  2024cites this paper
• Harnessing innate immune pathways for therapeutic advancement in cancer

  2024cites this paper
• Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors.

  2024cites this paper
• Helicobacter pylori infection and inflammasomes

  2024cites this paper
• Mechanisms and effects of NLRP3 in digestive cancers

  2024cites this paper
• Canonical and non-canonical functions of NLRP3

  2023cites this paper
• Euphorbia factor L2 suppresses the generation of liver metastatic ascites in breast cancer via inhibiting NLRP3 inflammasome activation

  2023cites this paper
• Promoting the proliferation of osteoarthritis chondrocytes by resolvin D1 regulating the NLRP3/caspase-1 signaling pathway.

  2023cites this paper
• Down‐regulation of OIP5‐AS1 inhibits obesity‐induced myocardial pyroptosis and miR‐22/NLRP3 inflammasome axis

  2023cites this paper
• The ‘speck’-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis

  2023cites this paper
• Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy

  2023cites this paper
• Role of NLRP3 inflammasome activation in HCC cell progression

  2023cites this paper
• Diversification and deleterious role of microbiome in gastric cancer

  2023cites this paper
• NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome

  2023cites this paper
• NLRP3: a new therapeutic target in alcoholic liver disease

  2023cites this paper
• Pyroptosis modulation by bacterial effector proteins.

  2023cites this paper
• Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

  2023cites this paper
• An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.

  2023cites this paper
• Mechanism of inflammasomes in cancer and targeted therapies

  2023cites this paper
• The regulation roles of miRNAs in Helicobacter pylori infection

  2023cites this paper
• The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation in Helicobacter pylori-associated gastritis by regulating ROS and autophagy

  2023cites this paper
• NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment

  2023cites this paper
• XBP1‐elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR‐22/lncRNA/KAT6B‐dependent NF‐κB signalling

  2023cites this paper
• A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer

  2022cites this paper
• ANKRD22 is a novel therapeutic target for gastric mucosal injury.

  2022cites this paper
• MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6.

  2022cites this paper
• Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition Receptor

  2022cites this paper
• MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses

  2022cites this paper
• Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders

  2022cites this paper
• Extracellular Vesicles From TNFα Preconditioned MSCs: Effects on Immunomodulation and Bone Regeneration

  2022cites this paper
• Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer

  2022cites this paper
• Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes

  2022cites this paper
• Capsaicin Inhibits Inflammation and Gastric Damage during H pylori Infection by Targeting NF-kB–miRNA Axis

  2022cites this paper
• Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells.

  2022cites this paper
• Emerging Role of Helicobacter pylori in the Immune Evasion Mechanism of Gastric Cancer: An Insight Into Tumor Microenvironment-Pathogen Interaction

  2022influential citation
• Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma

  2022cites this paper
• NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease

  2022cites this paper
• MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3

  2022cites this paper
• The role of non-coding RNA in the diagnosis and treatment of Helicobacter pylori-related gastric cancer, with a focus on inflammation and immune response

  2022influential citation
• Role of microRNAs in tumor progression among Iranian population: An overview

  2022cites this paper
• NLRP3 inflammasome in digestive diseases: From mechanism to therapy

  2022cites this paper
• Helicobacter Pylori and Gastric Cancer Progression

  2022cites this paper
• Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer

  2022cites this paper
• MicroRNA-mediated epigenetic regulation of inflammasomes in inflammatory responses and immunopathologies.

  2022cites this paper
• The prognostic value of NLRP1/NLRP3 and its relationship with immune infiltration in human gastric cancer

  2022cites this paper
• The role of NLRP3 inflammasome in digestive system malignancy

  2022cites this paper
• Association of VNTR Polymorphism of NLRP3 Gene With the Risk of Gastric Cancer

  2022cites this paper
• Clinical crosstalk between microRNAs and gastric cancer (Review).

  2021influential citation
• Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role

  2021cites this paper
• Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks

  2021influential citation
• TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

  2021cites this paper
• Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

  2021cites this paper
• Mechanisms of JARID1B Up-Regulation and Its Role in Helicobacter pylori-Induced Gastric Carcinogenesis

  2021cites this paper
• Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells

  2021cites this paper
• The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: new insight into gastric cancer pathogenesis.

  2021cites this paper
• Unravelling the pro-tumorigenic role of innate immune pattern recognition receptors in the gastric compartment

  2021cites this paper
• NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?

  2021cites this paper
• Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer

  2021cites this paper
• Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs

  2021cites this paper
• IP3R-mediated activation of BK channels contributes to mGluR5-induced protection against spinal cord ischemia-reperfusion injury.

  2021cites this paper
• Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.

  2021cites this paper
• Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma

  2021cites this paper
• RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.

  2021cites this paper
• miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma

  2021cites this paper
• Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications

  2021cites this paper
• Overexpression of NLRPs as Independent Indicator for Prognosis of Patients with Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Pyroptosis in Cancer: Friend or Foe?

  2021cites this paper
• Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer

  2021cites this paper
• MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.

  2021cites this paper
• An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes

  2021cites this paper